Top

Category: Research and Development


Manufacturing, News, Research and Development

Pharmaceutical Contract Development and Manufacturing Market | Exclusive Report on the Latest Trends and Market Revenues

April 8, 2021

Via: BioSpace

The rising popularity of outsourcing implementations across the healthcare industry due to the benefits such as affordability and less-time consumption will serve as a vital growth prospect for the pharmaceutical contract development and manufacturing market during the forecast period of […]


Clinical Trials, News, Research and Development

Researchers Expose Hidden Atomic Portrait of Antioxidant Enzyme

April 7, 2021

Via: Genetic Engineering and Biotechnology News

Oxidative stress is caused by an imbalance between production and accumulation of oxygen reactive species (ROS) in cells and cells . Manganese superoxide dismutase (MnSOD) is an antioxidant enzyme that protects the mitochondria from oxidative damage by using a mechanism […]


Biotech, Industry, Manufacturing, News, Research and Development, Vaccines

Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments

April 5, 2021

Via: BioSpace

Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]


Clinical Trials, News, Research and Development

Study identifies possible COVID-19 drugs — including several that are FDA-approved

April 2, 2021

Via: ScienceDaily

A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases. […]


Clinical Trials, FDA, Regulations, Research and Development

FDA green light for BMS, bluebird bio’s CAR-T therapy Abecma in multiple myeloma

March 30, 2021

Via: Pharma Times

Abecma (idecabtagene vicleucel; ide-cel) has been cleared for use in adult patients with relapsed or refractory multiple myeloma, after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 monoclonal antibody. In the […]


Clinical Trials, News, Research and Development

Clinical Trial Management System Market: Software is anticipated to be Most Lucrative Segment

March 30, 2021

Via: BioSpace

According to Transparency Market Research’s latest report on the global clinical trials management system (CTMS)market for the historical period 2017–2018 and forecast period 2019–2027, rising demand for new therapies and increasing research and developmental activities to drive the global clinical […]


Industry, Manufacturing, Research and Development, Vaccines

Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna

March 29, 2021

Via: World Pharma News

EMA’s human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU. New manufacturing site for AstraZeneca’s COVID-19 vaccine A new manufacturing site has been approved for the production […]


Manufacturing, Research and Development

Nexus Pharmaceuticals Announces Verbal to Occupy Authorization

March 26, 2021

Via: BioSpace

Lincolnshire, Illinois—Nexus Pharmaceuticals, Inc. is pleased to announce that it has received authorization to occupy its new pharmaceutical manufacturing facility from the Village of Pleasant Prairie, Wisconsin. Nexus Pharmaceuticals, which specializes in developing innovative processes to manufacture specialty and generic […]


Clinical Trials, Research and Development

Report urges pharma companies to utilise synthetic data in clinical trials

March 24, 2021

Via: Pharma Times

Synthetic data is based on real-world data sets, used to accurately predict the ‘synthetic patient profile’ and deploy a virtual cohort in a clinical trial. The report is the first in a series exploring the use of synthetic data in […]


Cell and Gene Therapy, Clinical Trials, Industry, Research and Development

Novel cancer-fighting gene therapy enters phase I clinical trial

March 18, 2021

Via: Medical News

Researchers from the MDC and Charité have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize and fight cancer cells. The safety of the novel therapy is now being tested on […]


Biotech, Clinical Trials, Industry, Research and Development

A first-of-its-kind mRNA drug falls short in cystic fibrosis

March 18, 2021

Via: Biopharma Dive

Messenger RNA technology, which uses synthetic, genetic material to teach the body to make helpful proteins, has come of age over the past year. When the coronavirus pandemic took hold in 2020, the technology was uniquely suited to meet the […]


Clinical Trials, Industry, Research and Development, Vaccines

Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results in Non-Human Primates Vaccinated with TNX-1800 and Challenged with Live SARS-CoV-2

March 17, 2021

Via: BioSpace

Tonix Pharmaceuticals, Inc.. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced preliminary results following vaccination of non-human primates with TNX-1800 (modified horsepox virus, live vaccine), a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 […]